InsidersTradesSigma
Follow the ALK-Abelló share price and the full management transaction log of the company, a publicly traded company based in Denmark. Shares trade on DK DK, under the supervision of Finanstilsynet DK. Operating in the Health Care sector, ALK-Abelló has logged 0 reports. Market capitalisation: €50.6bn. All data is accessible without an account.
Analysts rate ALK-Abelló Strong Buy (bullish), based on 4 analysts. Average price target: DKK 298.75.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
0 of 0 declarations
ALK-Abelló is a company focused on developing treatments for allergies, particularly through immunotherapy. It is listed on the XCSE market.